Dow Up 0.51% Nasdaq Up 0.24%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
32.38 Up 0.37(1.16%) 4:00PM EST
|After Hours : 32.00 Down 0.38 (1.17%) 5:04PM EST
Prev Close:32.01
Open:32.37
Bid:30.20 x 600
Ask:N/A
1y Target Est:37.92
Beta:0.63
Earnings Date:Feb 2 - Feb 6 (Est.)
Day's Range:31.99 - 32.52
52wk Range:20.02 - 42.50
Volume:663,938
Avg Vol (3m):753,872
Market Cap:2.36B
P/E (ttm):18.24
EPS (ttm):1.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNUp 1.16%2.36B
ABTUp 0.07%65.97B

Key Statistics

Forward P/E (1 yr):14.72
P/S (ttm):3.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.86
Quarterly EPS Est (Dec-14) :0.35
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback